CTI BioPharma (CTIC) Reports $10M Milestone Payment from Teva Pharmaceuticals (TEVA) for TRISENOX

February 11, 2019 7:08 AM
CTI BioPharma Corp. (NASDAQ: CTIC) today announced that it has received a $10 million milestone payment from Teva Pharmaceutical ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News

Next Articles